what are the different glp-1 drugs Market Overview: Agonists and Obesity Market | Blog GLP-1s for Weight Loss: What

Studies show GLP-1s help decrease weight, improve metabolic complications, lower flares and stiffness, and may slow joint damage when combined with DMARDs or biologics

Dyslipidemia in obesity: mechanisms and potential targets

Note: Market size and forecast figures in this report are generated using Mordor Intelligences proprietary estimation framework, updated with the latest available data and insights as of January 2026

10.1186/s12933-014-0171-2 17

and Kowa Company, Ltd.) [10] Teneligliptin (approved in Japan as Tenelia in 2012) [11] Alogliptin (FDA approved in 2013 as Nesina/Vipidia, and marketed by Takeda Pharmaceutical Company) Trelagliptin (approved for use in Japan as Zafatek/Wedica in 2015) Omarigliptin (MK-3102